Cigna-Express Scripts cap out-of-pocket 30-day insulin costs at $25

Cigna and Express Scripts launched a program that limits members’ out-of-pocket insulin costs to $25 for a 30-day supply, the companies said April 3.

Advertisement

The Patient Assurance Program targets members of health plans with nongovernment pharmacy plans managed by Express Scripts. The program, available to members of Cigna and other health plans, will lower out-of-pocket costs for most members without an increase in plan prices.

In comparison, insulin users managed by Cigna and Express Scripts paid, on average, $41.50 out of pocket for a 30-day supply in 2018.

Cigna and Express Scripts will roll out the program by transferring covered insulin products to a lower copayment. The companies are working with insulin makers to lower copayments to $25.

More articles on pharmacy:
10 hospitals seeking pharmacy leadership
Patent protection clause is latest stumbling block for revised NAFTA
Dr. Reddy’s legal win expected to lower cost of opioid addiction treatment

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

How Leading Pharmacies Stay Stocked And Protect Margins

Thursday, July 23
12:00 PM - 1:00 PM CDT

Presenters: Calvin Hunsicker, SureCostChad O’Connor, SureCost

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.